RELATIONSHIP OF GALECTIN-3 WITH HEMODYNAMIC PARAMETERS OF PATIENTS WITH CHRONIC HEART FAILURE

被引:0
|
作者
Nurillaeva, N. M. [1 ]
Qurbonov, A. K. [2 ]
Nasretdenova, D. O. [3 ]
机构
[1] Tashkent Med Acad, Internal Dis 21, Tashkent, Uzbekistan
[2] Tashkent Med Acad, Internal Dis 23, Tashkent, Uzbekistan
[3] Tashkent Med Acad, Internal Dis & Dermatovenerol, Urgench Branch, Tashkent, Uzbekistan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P564
引用
收藏
页码:E235 / E235
页数:1
相关论文
共 50 条
  • [41] Galectin-3 in heart failure patients: marker or mediator of renal insufficiency?
    Zamora, E.
    Lupon, J.
    De Antonio, M.
    Galan, A.
    Domingo, M.
    Urrutia, A.
    Gonzalez, B.
    Diez, C.
    Troya, M.
    Bayes-Genis, A.
    EUROPEAN HEART JOURNAL, 2014, 35 : 14 - 14
  • [42] Relationship of Plasma Galectin-3 to Renal Function in Patients With Heart Failure: Effects of Clinical Status, Pathophysiology of Heart Failure, and Presence or Absence of Heart Failure
    Gopal, Deepa M.
    Kommineni, Maya
    Ayalon, Nir
    Koelbl, Christian
    Ayalon, Rivka
    Biolo, Andreia
    Dember, Laura M.
    Downing, Jill
    Siwik, Deborah A.
    Liang, Chang-seng
    Colucci, Wilson S.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2012, 1 (05):
  • [43] The prognostic value of plasma galectin-3 in chronic heart failure patients treated with mineralocorticoid receptor antagonists
    Rouet, P.
    Koukoui, F.
    Desmoulin, F.
    Barutaut, M.
    Caubere, C.
    Berry, M.
    Evaristi, M.
    Smih, F.
    Galinier, M.
    EUROPEAN HEART JOURNAL, 2014, 35 : 673 - 673
  • [44] Galectin-3 in patients with chronic heart failure: association with oxidative stress, inflammation, renal dysfunction and prognosis
    Medvedeva, Elena A.
    Berezin, Ivan I.
    Surkova, Elena A.
    Yaranov, Dmitry M.
    Shchukin, Yuri V.
    MINERVA CARDIOANGIOLOGICA, 2016, 64 (06): : 595 - 602
  • [45] Galectin-3 and ST-2: association with inflammation and renal dysfunction in patients with chronic heart failure
    Medvedeva, E. A. Elena
    Shiljaeva, N. V.
    Shchukin, Y. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 393 - 393
  • [46] Lack of association of galectin-3 with myocardial fibrosis in patients with chronic stable heart failure of hypertensive origin
    Lopez Salazar, B.
    Gonzalez Miqueo, A.
    Querejeta Iraola, R.
    Larman Tellechea, M.
    Diez Martinez, J.
    CARDIOVASCULAR RESEARCH, 2014, 103
  • [47] Prognostic value of galectin-3 and cardiac extracellular matrix markers in patients with chronic systolic heart failure
    Lin, Yen-Hung
    Wu, Xue-Ming
    Hsu, Tse-Pin
    Chen, Yenh-Hsein
    Wu, Yen-Wen
    Ho, Yi-Lwun
    Chen, Ming-Fong
    CIRCULATION, 2012, 125 (19) : E691 - E691
  • [48] Galectin-3, a novel marker of macrophage activity, predicts outcome in patients with stable chronic heart failure
    Lok, Dirk
    van der Meer, Peter
    de la Porte, Pieta Bruggink-Andre
    Lipsic, Erik
    van Wijngaarden, Jan
    van Veldhuisen, Dirk Jan
    Pinto, Ygal
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 98A - 98A
  • [49] The role of galectin-3 in heart failure and cardiovascular disease
    Zhong, Xiao
    Qian, Xiaoqian
    Chen, Guangping
    Song, Xiang
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2019, 46 (03): : 197 - 203
  • [50] Galectin-3: A Modifiable Risk Factor in Heart Failure
    de Boer, Rudolf A.
    van der Velde, A. Rogier
    Mueller, Christian
    van Veldhuisen, Dirk J.
    Anker, Stefan D.
    Peacock, W. Frank
    Adams, Kirkwood F.
    Maisel, Alan
    CARDIOVASCULAR DRUGS AND THERAPY, 2014, 28 (03) : 237 - 246